Record Date

7th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir/ Madam, Sub.: Disclosure under Regulation 42 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Ref.: Record date in the matter of Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders ==================================================================== This is further to our earlier intimations dated 6th July, 2026 and 7th July, 2026 in connection with Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited (“Transferor Company” or “JB Chemicals”) with Torrent Pharmaceuticals Limited (“Company” or “Transferee Company” or “Torrent Pharma”) and their respective shareholders under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (“Scheme”) read with the rules framed thereunder sanctioned by the Hon’ble National Company Law Tribunal, Ahmedabad Bench (‘Hon’ble NCLT’) vide its order dated 6th July, 2026 (“Order”). In terms of the Scheme, the Company has, in consultation with JB Chemicals, fixed Friday, 17th July, 2026, as the Record Date for the purpose of determining the shareholders of JB Chemicals who shall be entitled to receive fully paid-up equity shares of Torrent Pharma as per the share exchange ratio set out in the Scheme i.e. 51 fully paid-up equity shares of Torrent Pharma having face value of Rs. 5 each for every 100 fully paid-up equity shares of Re. 1 each in JB Chemicals. Email – investorservices@torrentpharma.com Kindly take note of the above. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com